GA: gestational age; gw: gestational week *: number of samples analysed
for anti-D
concentration per woman
Legends
Figure 1. Anti-D concentration (IU/L) at inclusion in the study at week
38±1, n=39, after administration of RAADP 1500 IU in gestational week
28. The dotted line represents LOD for detection of Anti-D with
type-and-screen, 10 IU/L (2 µg/L), with 17/39 below LOD.
Figure 2. Increase of anti-D IgG after administration of RAADP 1500 IU
in pregnancy week 38 was quantified by flow cytometry one week after
administration. Linear regression analysis showed a significant
correlation to body mass index, p=0.0118, n=39.
Figure 3.
Concentrations of anti-D measured by flow cytometry at different time
points after delivery. Data are shown as box plots with median values
and quartiles in the box and the range as whiskers. n = no of anti-D
analyses performed at delivery and each week after delivery.